search
depression
Trends
- 1Forecasters dismiss Democratic fears of polling 'sugar-high'●Election forecasters don’t see polling ‘sugar-high’ Democrats fear — for now
Election forecasters say recent polling gains that have encouraged Democrats do not represent a lasting surge, and they see no statistical evidence of a so-called 'sugar-high' in the numbers — at least for now. Democrats have voiced concern that overly optimistic polling could depress turnout or lead to complacency, but modelers note current data does not yet show the kind of inflated bounce the party fears.
- 2
The Economist argues that falling student test scores around the world amount to a slow-moving catastrophe, with learning losses that could depress economic growth and widen inequality for decades. The leader column is drawing wide attention, with readers debating causes ranging from pandemic school closures to smartphones and changing teaching methods, and what governments should do to reverse the decline.
- 3Confusion and worry among Americans raises election turnout questions▼Americans are confused and worried about elections. Will that impact turnout?
Confusion and anxiety among American voters about the electoral process is emerging as a concern heading into the elections. Commentators are asking whether widespread uncertainty and distrust could depress turnout at the polls, a question that matters for both parties as campaigns push to mobilize supporters.
- 4Scientists identify stress-triggered molecular switch behind depression▼Scientists uncover a stress-triggered molecular switch that drives depression
Researchers report the discovery of a molecular switch activated by stress that appears to drive depression, offering a possible biological explanation for how chronic stress leads to depressive symptoms. The finding could point toward new drug targets and treatments that work on the underlying mechanism rather than symptoms alone. Details of the study, including the researchers involved and where it was published, were not immediately available.
- 5Arizona Moms Campaign to Protect Maternal Mental Health Line▼Arizona moms push to protect maternal mental health help line
Mothers in Arizona are campaigning to preserve the state's maternal mental health help line, a service that offers support to women experiencing postpartum depression and other perinatal mental health challenges. The push comes amid concerns the hotline could lose funding or be discontinued. Supporters say the line provides vital, sometimes lifesaving assistance to new mothers, and they are urging state lawmakers to protect its future.
- 6Annual fundraiser supports veteran mental health services▼Annual event raises money for veteran mental health
An annual charity event has raised funds for veterans' mental health programs, according to local news coverage. The event brings together community members to support services addressing mental health challenges faced by former service members, including conditions like PTSD and depression, with proceeds directed toward organizations providing care and support to veterans in need.
- 7New Deal art exhibition opens at Crow Museum in Dallas▼New Deal art is a big deal at Crow Museum at UT Dallas
The Crow Museum of Asian Art at UT Dallas is presenting an exhibition of New Deal-era art, drawing local media attention in Dallas-Fort Worth. The show highlights works created under the federal arts programs of the 1930s, a period when the US government employed artists during the Great Depression. Coverage frames the exhibition as a significant cultural event for the university and the city's museum scene.
- 8Psychedelic Drugs Market Set to Grow Through 2035●Psychedelic Drugs Market Forecast to 2035: Demand Accelerates on Mental Health Crisis and Regulatory Breakthroughs
A new market forecast projects the psychedelic drugs market to expand through 2035, driven by rising demand for mental health treatments and regulatory breakthroughs in approving psychedelic-based therapies. Industry analysts say growing acceptance of substances like psilocybin and MDMA for conditions such as depression and PTSD is attracting investment, though clinical and legal hurdles remain ahead of widespread adoption.